ACR Appropriateness Criteria® on Recurrent Symptoms Following Lower-Extremity Angioplasty

Journal of the American College of Radiology

Volumn 5, Issue 12, 2008, Pages 1176-1180

  Rybicki, Frank J ^a   Nallamshetty, Leelakrishna ^a   Yucel, E Kent ^b   Holtzman, Stephen R ^c   Baum, Richard A ^a   Foley, W Dennis ^d   Ho, Vincent B ^e   Mammen, Leena ^f   Narra, Vamsidhar R ^g   Stein, Barry ^h   Moneta, Gregory L ⁱ  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f Advanced Radiology Services   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Jefferson X Ray Group Inc   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

angioplasty; claudication; computed tomography angiography; magnetic resonance angiography; threatened limb

Indexed keywords

ANGIOPLASTY; ANKLE BRACHIAL INDEX; BLOOD VESSEL CALCIFICATION; CLASSIFICATION ALGORITHM; CLAUDICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; FOLLOW UP; HUMAN; LEG BLOOD VESSEL; LEG ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; ULTRASOUND;

EID: 56249114137     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2008.08.010     Document Type: Review

References (37)

1. Capek P., McLean G.K., and Berkowitz H.D. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83 (1991) I70-I80
2. Johnston K.W. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 183 (1992) 767-771
3. Sabeti S., Schillinger M., Amighi J., et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 232 (2004) 516-521
4. Ahn S.S., Rutherford R.B., Becker G.J., et al. Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg 17 (1993) 1103-1107
5. Decrinis M., Doder S., Stark G., and Pilger E. A prospective evaluation of sensitivity and specificity of the ankle/brachial index in the follow-up of superficial femoral artery occlusions treated by angioplasty. Clin Invest 72 (1994) 592-597
6. Hartmann A., Gehring A., Vallbracht C., et al. Noninvasive methods in the early detection of restenosis after percutaneous transluminal angioplasty in peripheral arteries. Cardiology 84 (1994) 25-32
7. Matsi P.J., and Manninen H.I. Impact of different patency criteria on long-term results of femoropopliteal angioplasty: analysis of 106 consecutive patients with claudication. J Vasc Interv Radiol 6 (1995) 159-163
8. Leiner T., Kessels A.G., Nelemans P.J., et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology 235 (2005) 699-708
9. Minar E., Ahmadi A., Koppensteiner R., et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 91 (1995) 2167-2173
10. Adriaensen M.E., Kock M.C., Stijnen T., et al. Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations. Radiology 233 (2004) 385-391
11. Martin M.L., Tay K.H., Flak B., et al. Multidetector CT angiography of the aortoiliac system and lower extremities: a prospective comparison with digital subtraction angiography. AJR Am J Roentgenol 180 (2003) 1085-1091
12. Rieker O., Duber C., Schmiedt W., von Zitzewitz H., Schweden F., and Thelen M. Prospective comparison of CT angiography of the legs with intraarterial digital subtraction angiography. AJR Am J Roentgenol 166 (1996) 269-276
13. Willmann J.K., Baumert B., Schertler T., et al. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography. Radiology 236 (2005) 1083-1093
14. Ofer A., Nitecki S.S., Linn S., et al. Multidetector CT angiography of peripheral vascular disease: a prospective comparison with intraarterial digital subtraction angiography. AJR Am J Roentgenol 180 (2003) 719-724
15. Ouwendijk R., Kock M.C., van Dijk L.C., van Sambeek M.R., Stijnen T., and Hunink M.G. Vessel wall calcifications at multi-detector row CT angiography in patients with peripheral arterial disease: effect on clinical utility and clinical predictors. Radiology 241 (2006) 603-608
16. Ho V.B., and Corse W.R. MR angiography of the abdominal aorta and peripheral vessels. Radiol Clin North Am 41 (2003) 115-144
17. Tatli S., Lipton M.J., Davison B.D., Skorstad R.B., and Yucel E.K. From the RSNA refresher courses: MR imaging of aortic and peripheral vascular disease. RadioGraphics 23 (2003) S59-S78
18. Andreisek G., Pfammatter T., Goepfert K., et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology 242 (2007) 610-620
19. Elsman B.H., Legemate D.A., van der Heijden F.H., de Vos H.J., Mali W.P., and Eikelboom B.C. Impact of ultrasonographic duplex scanning on therapeutic decision making in lower-limb arterial disease. Br J Surg 82 (1995) 630-633
20. Baum R.A., Rutter C.M., Sunshine J.H., et al. American College of Radiology Rapid Technology Assessment Group. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. JAMA 274 (1995) 875-880
21. Davis C.P., Schopke W.D., Seifert B., Schneider E., Pfammatter T., and Debatin J.F. MR angiography of patients with peripheral arterial disease before and after transluminal angioplasty. AJR Am J Roentgenol 168 (1997) 1027-1034
22. Link J., Steffens J.C., Brossmann J., Graessner J., Hackethal S., and Heller M. Iliofemoral arterial occlusive disease: contrast-enhanced MR angiography for preinterventional evaluation and follow-up after stent placement. Radiology 212 (1999) 371-377
23. Lundin P., Svensson A., Henriksen E., et al. Imaging of aortoiliac arterial disease. Duplex ultrasound and MR angiography versus digital subtraction angiography. Acta Radiol 41 (2000) 125-132
24. Meaney J.F., Ridgway J.P., Chakraverty S., et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211 (1999) 59-67
25. Mitsuzaki K., Yamashita Y., Sakaguchi T., Ogata I., Takahashi M., and Hiai Y. Abdomen, pelvis, and extremities: diagnostic accuracy of dynamic contrast-enhanced turbo MR angiography compared with conventional angiography-initial experience. Radiology 216 (2000) 909-915
26. Nelemans P.J., Leiner T., de Vet H.C., and van Engelshoven J.M. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology 217 (2000) 105-114
27. Sueyoshi E., Sakamoto I., Matsuoka Y., et al. Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography. Radiology 210 (1999) 683-688
28. Visser K., and Hunink M.G. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US-a meta-analysis. Radiology 216 (2000) 67-77
29. Winchester P.A., Lee H.M., Khilnani N.M., et al. Comparison of two-dimensional MR digital subtraction angiography of the lower extremity with x-ray angiography. J Vasc Interv Radiol 9 (1998) 891-899
30. Yucel E.K., Kaufman J.A., Geller S.C., and Waltman A.C. Atherosclerotic occlusive disease of the lower extremity: prospective evaluation with two-dimensional time-of-flight MR angiography. Radiology 187 (1993) 637-641
31. Broome D.R., Girguis M.S., Baron P.W., Cottrell A.C., Kjellin I., and Kirk G.A. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 188 (2007) 586-592
32. Ersoy H., and Rybicki F.J. Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 26 (2007) 1190-1197
33. Sadowski E.A., Bennett L.K., Chan M.R., et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 243 (2007) 148-157
34. Miyazaki M., Sugiura S., Tateishi F., Wada H., Kassai Y., and Abe H. Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 12 (2000) 776-783
35. Miyazaki M., Takai H., Sugiura S., Wada H., Kuwahara R., and Urata J. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 227 (2003) 890-896
36. Kanal E., Barkovich A.J., Bell C., et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 188 (2007) 1447-1474
37. US Food and Drug Administration. Gadolinium-based contrast agents for magnetic resonance imaging (marketed as Magnevist, MultiHance, Omniscan, OptiMARK, ProHance). http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705HCP.pdf Accessed October 10, 2008